Characterising the mechanisms through which the HPA axis maintains homeostasis in health and disease: A multiscale, multidisciplinary approach
Characterising the mechanisms through which the HPA axis maintains homeostasis in health and disease: A multiscale, multidisciplinary approach
批准号:
MR/J008893/1
负责人:
Stafford Lightman
金额:
$277.11万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --
中文摘要
下丘脑-垂体-肾上腺(HPA)轴动态调节应激激素皮质醇的水平。这个轴对维持体内平衡至关重要,是提供快速反应和防御急性压力的主要激素系统。不幸的是,当长期暴露在压力下时,HPA的反应会变得不适应,并使个体容易患病——尤其是心血管、代谢和认知功能障碍。现在有越来越多的证据表明,为了实现最佳功能——从细胞反应到行为——皮质醇水平的波动是必需的。与自然状态完全相反,因炎症或恶性疾病而接受激素替代和糖皮质激素治疗的患者通常暴露于恒定水平的长效合成类固醇。这种给药模式是在我们了解糖皮质激素节律性的重要性之前发展起来的,可能会限制治疗的效果,并导致与长期使用合成糖皮质激素相关的非常高的副作用。因此,我们现在重新评估糖皮质激素的治疗应用是非常重要的,要做到这一点,我们必须了解控制身体内源性类固醇生产的生物机制,以及这些激素循环水平如何帮助优化身体对环境影响的反应,并维持正常的内部调节过程。为了解决这些问题,我们将采用的方法是通过开发一套计算和数学模型来整合从细胞、组织和整个系统研究中获得的数据。使用这些模型,我们将为实验观察的可能产生者探索数据,并指导新实验的发展,以验证我们的数学模型的预测。考虑到hpa轴的复杂性,动态活动模式从系统内许多空间和时间尺度的相互作用中出现,数学模型提供了一套自然的工具来询问我们的数据。最终,我们计划通过开发混合测试方法来完全集成我们的方法。这意味着我们将我们希望通过实验研究的系统的一部分与系统其余部分的计算模型结合起来。这将使我们能够研究特定的子组件,就好像它仍然是整个系统的一部分一样。这种方法对于适当查明导致与疾病和衰老有关的节律性紊乱的生物机制至关重要,因为系统中孤立的一个组成部分的行为可能不能反映其在整个系统中整合时的行为。
英文摘要
The hypothalamic-pituitary-adrenal (HPA) axis dynamically regulates levels of the stress hormone cortisol. This axis is critical for the maintenance of homeostasis, and is the major hormonal system that provides a rapid response and defence against acute stress. Unfortunately, when exposure to stress becomes prolonged, the response of the HPA can become maladaptive and predispose an individual to illness - particularly cardiovascular, metabolic and cognitive dysfunction. There is now an increasing body of evidence that in order to achieve optimal function - from cellular response through to behaviour - oscillating levels of cortisol are required. In complete contrast to the natural state, patients undergoing both hormone replacement and glucocorticoid therapy for inflammatory or malignant disease are typically exposed to constant levels of long-acting synthetic steroids. This pattern of delivery was developed before we understood the importance of glucocorticoid rhythmicity and may well limit efficacy of treatment as well as contribute to the very high levels of side-effects associated with the long-term use of synthetic glucocorticoids. It is therefore very important that we now re-evaluate the therapeutic application of glucocorticoids and to do so it is crucial that we understand the biological mechanisms governing the body's endogenous production of these steroids and further how these cycling levels of hormones help to optimise the body's response to environmental influences and to maintain normal internal regulatory processes. To address these questions, the approach we will pursue is to integrate data obtained from cellular, tissue and whole systems studies through the development of a suite of computational and mathematical models .Using these models we shall probe the data for the likely generators of our experimental observations and to guide the development of new experiments that can validate the predictions of our mathematical models. Given the complexity of the HPA-axis, where dynamic patterns of activity emerge from interactions across many spatial and temporal scales within the system, mathematical models provide a natural suite of tools with which to interrogate our data. Ultimately we plan to fully integrate our approaches through the development of a hybrid testing approach. This means that we couple part of the system that we wish to study experimentally, with a computational model of the rest of the system. This will enable us to study the specific subcomponent as if it remained part of the whole system. Such an approach will be crucial to appropriately identify the biological mechanisms that give rise to disrupted rhythmicity associated with disease and ageing, since the behaviour of a component of a system in isolation may not be reflective of its behaviour when integrated within the whole system.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0147293
发表时间:
2016
期刊:
PloS one
影响因子:
3.7
作者:
[Hoeller AA, Costa AP, Bicca MA, Matheus FC, Lach G, Spiga F, Lightman SL, Walz R, Collingridge GL, Bortolotto ZA, de Lima TC]
通讯作者:
de Lima TC
Dynamic responses of the adrenal steroidogenic regulatory network
肾上腺类固醇生成调节网络的动态反应
DOI:
10.1530/ey.15.8.4
发表时间:
2018
期刊:
Yearbook of Paediatric Endocrinology
影响因子:
--
作者:
[F S]
通讯作者:
F S
DOI:
10.1016/j.mce.2021.111195
发表时间:
2021-04-15
期刊:
Molecular and cellular endocrinology
影响因子:
4.1
作者:
[Fudulu DP, Horn G, Hazell G, Lefrançois-Martinez AM, Martinez A, Angelini GD, Lightman SL, Spiga F]
通讯作者:
Spiga F
DOI:
10.1080/10253890.2018.1470238
发表时间:
2018-09
期刊:
Stress (Amsterdam, Netherlands)
影响因子:
--
作者:
[Gjerstad JK, Lightman SL, Spiga F]
通讯作者:
Spiga F
DOI:
10.1097/ccm.0000000000000773
发表时间:
2015-04
期刊:
Critical care medicine
影响因子:
8.8
作者:
[Gibbison B, Spiga F, Walker JJ, Russell GM, Stevenson K, Kershaw Y, Zhao Z, Henley D, Angelini GD, Lightman SL]
通讯作者:
Lightman SL
共 6 条
Development and integration of a cortisol sensor with real-time read-out to an ambulatory microdialysis sampling system
-
批准号:BB/T004177/1
-
项目类别:Research Grant
-
资助金额:$81.63万
-
财政年份:2020
-
负责人:Stafford Lightman
-
依托单位:
Glucocorticoid dynamics in health and disease
-
批准号:MR/R010919/1
-
项目类别:Research Grant
-
资助金额:$235.42万
-
财政年份:2018
-
负责人:Stafford Lightman
-
依托单位:
Ambulatory microdialysis sampling system
-
批准号:BB/M019268/1
-
项目类别:Research Grant
-
资助金额:$22.86万
-
财政年份:2015
-
负责人:Stafford Lightman
-
依托单位:
Ambulatory microdialysis sampling system
-
批准号:BB/M005089/1
-
项目类别:Research Grant
-
资助金额:$1.36万
-
财政年份:2014
-
负责人:Stafford Lightman
-
依托单位:
The mineralocorticoid receptor in glucocorticoid-mediated gene regulation: MR/GR interactions and chromatin accessibility as mechanisms
-
批准号:BB/L007622/1
-
项目类别:Research Grant
-
资助金额:$87.28万
-
财政年份:2014
-
负责人:Stafford Lightman
-
依托单位:
Pulsed Glucocorticoid Replacement Therapy
-
批准号:MR/J012548/1
-
项目类别:Research Grant
-
资助金额:$94.13万
-
财政年份:2013
-
负责人:Stafford Lightman
-
依托单位:
Hypothalamic-pituitary modulation of corticosterone pulsatility
-
批准号:BB/H015779/1
-
项目类别:Research Grant
-
资助金额:$35.6万
-
财政年份:2010
-
负责人:Stafford Lightman
-
依托单位:
The regulation of circadian and ultradian rhythmicity of circulating glucocorticoid hormones and their role in the optimisation of limbic activity
-
批准号:BB/G00403X/1
-
项目类别:Research Grant
-
资助金额:$75.92万
-
财政年份:2009
-
负责人:Stafford Lightman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
-
批准号:82371255
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹立
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
-
批准号:82372015
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:熊丽琴
-
依托单位: